Nims online platform lets users track their workouts online.
The platform, which has raised $1.5 million in funding from some of the world’s biggest companies, will allow users to track their workout progress online and on a dashboard for each workout, according to a statement on the company’s website.
The dashboard is part of the platform’s upcoming $3 million Series A funding round.
Nims has raised more than $1 million from investors including Twitter, Spotify, Kleiner Perkins Caufield & Byers, Digital Trends and CapitalOne, among others.
The company has also raised more money from others.
In an interview with Business Insider, Nims CEO Adam Zimbeck said he expects the company to grow into a full-fledged training platform in the coming years.
The company said the launch of the dashboard will allow Nims users to see how much time has been spent on each workout and how they performed during that time.
Nims is partnering with leading athletes to provide users with real-time statistics on each session.
The Nims dashboard will include stats on the duration of each session, the intensity of each workout session, time spent on the exercise, and number of repetitions completed.
It will also show a graph of how much of the time spent doing each activity has been accounted for by the athlete, Zimbelbeck said.
The dashboard also lets users view a list of workouts in progress that have been completed, which is particularly useful for people looking to add more time to their workout schedule.
Nimims users can view their workout logs from the dashboard, and they can also track their progress over time by logging in to the platform.
The launch of Nims will also bring the platform closer to the millions of people using fitness apps on the App Store, Zimbald said.
Users can view the results of all their workouts on the dashboard and can also view results on a calendar of their workouts.
The technology platform will also offer analytics on the activity of the user, the types of workouts they have completed, the amount of time spent, and their results, he added.
For more information on Nims, visit nims.com